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OBJECTIVES This study was aimed at evaluating the effects of phenylephrine infusion on the occurrence of
focal atrial fibrillation (AF).
BACKGROUND Paroxysmal AF can be initiated by ectopic atrial beats originating in the pulmonary vein (PV)
or superior vena cava (SVC). The effect of change in autonomic tone on this focal AF is
unknown.
METHODS This study included 12 patients with frequent bursts of AF documented by 24-h Holter
monitoring. The number and coupling interval of spontaneous ectopic activity and bursts of
AF were evaluated for 1 min before and after phenylephrine (2 to 3 mg/kg) injection.
RESULTS After detailed mapping, four patients had a focus located in the left superior PV, six in the
right superior PV and two in the SVC. In 10 patients with AF foci originating in the PVs,
the frequency of ectopic activity (19.5 6 27.4 vs. 11.4 6 22.9 beats/min, p 5 0.059) was
reduced as well as AF bursts (14 6 3 vs. 1.8 6 2.7 bursts/min, p 5 0.005) before versus after
phenylephrine injection; the minimal coupling interval of ectopic activity and AF bursts
became longer compared with baseline. The maximal percent increase in sinus cycle length
after phenylephrine injection was significantly greater in patients with complete suppression
of AF compared with those with partial suppression (43 6 19 vs. 14 6 5%, p 5 0.01).
However, no significant effect of phenylephrine on AF originating in the SVC was found.
CONCLUSIONS Change in autonomic tone induced by phenylephrine injection was effective in suppressing
focal AF originating in the PVs but not in the SVC. (J Am Coll Cardiol 2000;36:788–93)
© 2000 by the American College of Cardiology
It is now considered that paroxysmal atrial fibrillation (AF)
may be initiated by a single or repetitive ectopic atrial beats
originating from a firing focus (1,2). The sources of a firing
focus have been located mostly in the pulmonary veins (PV),
as well as in the superior vena cava (SVC), the coronary
sinus ostium and the crista terminalis (1–4). Although
clinical observation indicates that onset of paroxysmal AF is
associated with change of vagal or sympathetic activity, the
role of autonomic influences in the initiation of focal AF
originating in the PVs or SVC is still unknown (5). In a
previous report, we demonstrated that infusion of isopro-
terenol could provoke spontaneous occurrence of focal AF
originating in the PVs, and beta-adrenergic blocking agents
could suppress initiation of this focal AF (6). Abnormal
automaticity enhanced by an increase in sympathetic tone
may be the underlying mechanism of focal AF (7,8). Based
on accentuated antagonism, we hypothesized that an in-
crease in vagal tone can decrease automaticity and suppress
initiation of focal AF (9).
The purpose of this study was to evaluate the effect of
change in autonomic tone induced by phenylephrine infu-
sion on the occurrence of focal AF originating in the PVs or
SVC.
METHODS
Patients. The study population consisted of 12 patients (11
men and 1 woman, mean age 63 6 19 years) with frequent
bursts of paroxysmal AF documented by 24-h Holter
monitoring. All of them were drug-refractory and referred
to this institute for electrophysiologic study and radiofre-
quency ablation. Seven patients had structural heart dis-
eases, and three patients had left atrial enlargement
(Table 1).
Electrophysiological study. Each patient gave informed
consent. All antiarrhythmic drugs were discontinued for at
least five half-lives before the study. Two quadripolar
catheters (Mansfield Division, Boston Scientific Corp.,
Watertown, Massachusetts) with 2-mm interelectrode spac-
ing and 5-mm spacing between bipoles were placed in the
anterolateral right atrium and His bundle area via the right
or left femoral vein. A deflectable, duodecapolar catheter
(Daig Corp., Minnetonka, Minnesota) with 2-mm inter-
electrode spacing was placed in the SVC and posterior right
atrium via the right femoral vein. A deflectable, decapolar
catheter (Daig Corp., Minnetonka, Minnesota) with 2-mm
From the Division of Cardiology, Department of Medicine, National Yang-Ming
University School of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan,
R.O.C. This study was supported, in part, by grants from the National Science
Council (NSC 88-2314-B-075-090, 88-2314-B-010-093, 88-2314-B-010-094,
VGH-61, VGH-254) and Tzou’s Foundation (VGHYM-S4-30, VGHYM-S4-31),
Taipei, Taiwan, R.O.C.
Manuscript received November 12, 1999; revised manuscript received March 1,
2000, accepted April 13, 2000.
Journal of the American College of Cardiology Vol. 36, No. 3, 2000
© 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00
Published by Elsevier Science Inc. PII S0735-1097(00)00792-0
interelectrode spacing and 5-mm spacing between bipoles
was positioned in the coronary sinus via the right internal
jugular vein, with the proximal electrode pair at the ostium
as confirmed by contrast injection during fluoroscopy. After
an atrial transseptal procedure, two long sheaths (8-French,
Daig Corp., Minnetonka, Minnesota), SL1 for the right
PVs and SR0 for the left PVs, were put into the left atrium
through the interatrial septum (3,6). Two deflectable,
20 pole catheters (Daig Corp., Minnetonka, Minnesota)
with 2-mm interelectrode spacing were placed in the right
superior pulmonary vein (RSPV) and left superior pulmo-
nary vein (LSPV), or inferior PVs if necessary, guided by
the selective pulmonary venography with the first proximal
electrode pair straddling the ostium of the PV (3,6).
Intravenous heparin was administered in a dose of 2,000 to
3,000 U at half-hour intervals, if needed, to maintain the
activated clotting time .300 s after the atrial transseptal
procedure.
A programmed digital stimulator (DTU-215, Bloom
Associate Ltd., Reading, Pennsylvania) was used to deliver
electrical impulses of 2.0 ms in duration at twice the
diastolic threshold. Intracardiac bipolar electrograms were
displayed simultaneously with surface electrocardiogram on
a multichannel recorder (Cardiolab System, Prucka Engi-
neering, Houston, Texas) and stored on an optical disk. All
measurements were made with digital calipers at a sweep
speed of 100 to 200 mm/s. In the beginning, we waited to
find the spontaneous onset of bursts of AF by repetitive
ectopic atrial beats in the baseline or after infusion of
isoproterenol (up to 4 mg/min for 5 min). If no AF was
found, intermittent atrial pacing (8 to 12 beats) with cycle
length 250 to 300 ms from the right atrium or coronary
sinus was used to facilitate the occurrence of spontaneous
AF. If spontaneous AF did not appear, induction of
sustained AF followed by external cardioversion was per-
formed to observe the reinitiation of AF. The details of
provoking the spontaneous onset of bursts of AF were
described in a previous report (3).
Phenylephrine infusion. After bursts of paroxysmal AF
occurred spontaneously, endocardiac tracing and blood pres-
sure were recorded for a baseline period of 5 min. Phenyleph-
rine injection with a bolus dose of 2 mg/kg was then performed
to evaluate the magnitude of the resulting increase in systolic
blood pressure (10). In the case of inadequate blood pressure
response (,15 mm Hg increase), an additional dose of
1 mg/kg was given. The recording was continued until blood
pressure returned to the baseline. The peak effect of phenyl-
Abbreviations and Acronyms
AF 5 atrial fibrillation
LSPV 5 left superior pulmonary vein
PV 5 pulmonary vein
RSPV 5 right superior pulmonary vein
SVC 5 superior vena cava
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ephrine injection was defined as the time when there was a
maximal increase in sinus cycle length.
For each patient, the following variables were analyzed: 1)
a maximal percentage of increase in sinus cycle length, 2)
number and coupling interval of atrial premature beats
originating from an AF focus for 1 min before phenyleph-
rine injection, 3) number and coupling interval of bursts of
AF for 1 min before phenylephrine injection, 4) number and
coupling interval of atrial premature beats for 1 min after the
peak effect of phenylephrine injection, 5) number and
coupling interval of bursts of AF for 1 min after the peak
effect of phenylephrine injection.
Radiofrequency catheter ablation. The earliest activation
of the PV potential, or SVC potential, or right atrial
potential preceding the onset of spontaneous AF was tar-
geted for ablation. Radiofrequency energy was delivered to
that site with an EPT-1000 generator (EP Technologies,
Mountain View, California). Each application of radiofre-
quency energy was delivered for 20 to 40 s with a maximal
temperature setting of 60°C. If patients had burning pain,
cough or severe bradycardia, energy application was stopped
immediately, and the maximal temperature was reset to 50
to 55°C. Procedural success was defined as: no appearance
of spontaneous repetitive atrial premature beats or AF using
the same provocative protocol as before ablation. Heparin
(1,000 U/h) was continuously administered for 24 h, and
oral coumadin was given for two months with maintenance
of an international normalized ratio level between 2.0 and
3.0.
Statistical analysis. Quantitative values are expressed as
mean 6 SD. Statistical analysis was performed using
Mann-Whitney rank sum test for comparison of data in
different groups and Wilcoxon signed ranks test for paired
comparison. A p value of , 0.05 was considered significant.
RESULTS
Electrophysiologic characteristics. In the electrophysi-
ologic laboratory, one patient presented with bursts of AF,
and the other 11 patients were in sinus rhythm. After the
Figure 1. Shown are electrocardiogram lead V1, the tracing of left superior pulmonary vein (LSPV), right superior pulmonary vein (RSPV) and blood
pressure (BP). Note that frequent ectopic activity and bursts of atrial fibrillation originating in the LSPV disappear when BP is increased above control after
administration of phenylephrine (PHE).
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performance of provocative maneuvers, atrial premature
beats and bursts of AF occurred in the 11 patients (six by
isoproterenol infusion, three by atrial pacing during isopro-
terenol infusion and two by cardioversion of induced AF
followed by reinitiation). After detailed mapping of the
earliest activation preceding the onset of AF, four patients
had an initiating focus located in the LSPV, six in the
RSPV and two in the SVC as demonstrated in Table 1.
Effects of phenylephrine on frequency of atrial premature
beats and bursts of AF. In 10 patients with AF foci
originating in the PVs, phenylephrine increased systolic
blood pressure from 133 6 22 to 184 6 25 mm Hg, and
sinus cycle length increased from 708 6 91 to 927 6
174 ms. During the reflex bradycardia, ectopic activity was
completely suppressed in 3 of 10 patients. The mean
number of atrial premature beats for 1 min after the peak
Figure 2. (A) Before administration of phenylephrine, the minimal coupling interval of atrial fibrillation (AF) burst originating in the RSPV was 120 ms.
(B) After administration of phenylephrine, the minimal coupling interval of AF burst was prolonged to 172 ms. CSD 5 distal coronary sinus; CSM 5
middle coronary sinus; CSO 5 ostial coronary sinus; HRA 5 high right atrium; RSPV 5 right superior pulmonary vein.
791JACC Vol. 36, No. 3, 2000 Tai et al.
September 2000:788–93 Phenylephrine in Focal Atrial Fibrillation
effect of phenylephrine injection tended to be less than that
before phenylephrine injection (11.4 6 22.9 vs. 19.5 6
27.4, p 5 0.059). The minimal coupling interval of atrial
premature beats after phenylephrine injection was signifi-
cantly longer than that before phenylephrine injection in
seven patients with partial suppression (205 6 48 vs. 182 6
42 ms, p 5 0.018). During the reflex bradycardia, bursts of
AF were completely suppressed in 6 of 10 patients; it was
reduced by 76 6 6% in the remaining 4 patients (Fig. 1).
The mean number of AF bursts for 1 min after the peak
effect of phenylephrine injection was significantly less than
that before phenylephrine injection (1.8 6 2.7 vs. 14 6 3,
p 5 0.005). The mean minimal coupling interval of the first
beat of bursts of AF after phenylephrine injection was
significantly longer than that before phenylephrine injection
in the four patients with partial suppression (189 6 24 vs.
148 6 25 ms, p 5 0.048; Fig. 2). The maximal percentage
of increase in sinus cycle length after phenylephrine injec-
tion was significantly greater in patients with complete
suppression of AF compared with those with partial sup-
pression (43 6 19 vs. 14 6 5%, p 5 0.01).
In two patients with AF foci originating in the SVC,
adequate increase of systolic blood pressure (51 and
36 mm Hg, respectively) and sinus cycle length (26% and
16%, respectively) after phenylephrine injection was noted,
but the number and coupling interval of AF bursts did not
change, suggesting no effects of phenylephrine injection on
frequency of AF originating in the SVC (Table 1).
Radiofrequency ablation and follow-up. Radiofrequency
catheter ablation was successfully performed in all 12
patients without any complications. During the follow-up
period of 7.8 6 1.3 months, no patient had recurrence of
AF without antiarrhythmic drugs.
DISCUSSION
Major findings. In this study we first demonstrated that
change in autonomic tone after phenylephrine infusion
could completely or partially suppress ectopic activity and
bursts of AF originating in the PVs, but not in the SVC.
This finding suggested autonomic influence plays an impor-
tant role in the initiation and termination of focal AF.
Mechanism of paroxysmal AF originating in the PVs and
SVC. Although a focal source of AF has been demon-
strated in humans, the real mechanism of this AF is still not
clear. Cheung (8) demonstrated that the PV of the guinea-
pig can develop spontaneous activity and act as an ectopic
focus in atrial arrhythmia in the presence of ouabain.
Furthermore, he also reported that pace-making activity was
observed in cardiac cells at the distal end of the PVs;
noradrenaline could increase and acetylcholine could de-
crease the spontaneous activity from the PV (7). In a
previous study from this laboratory, the beta-blocker (pro-
pranolol) and calcium channel blocker (verapamil) were
effective in suppressing ectopic activity originating in the
PVs (6). Thus, the mechanism of focal AF originating in
the human PVs or SVC may be due to abnormal automa-
ticity.
Moreover, the results of this study suggest that the
mechanism of focal AF originating in the PVs or SVC may
be different from that of the so-called “vagal AF” in which
vagal activation results in enhancement of AF occurrence
(5). The promising results of linear lesions limited to the
right atrium in patients with idiopathic vagal AF by Gaita et
al. (11) further support the assumption that various clinical
patterns of AF may be due to different substrate sensitivity
to the autonomic nervous system (5).
Effects of phenylephrine infusion on ectopic activity and
AF originating in the PVs or SVC. In this study, change
in autonomic tone after phenylephrine infusion could com-
pletely or partially suppress ectopic activity and bursts of AF
originating in the PVs. Furthermore, the coupling intervals
of ectopic activity or AF increased after phenylephrine
infusion. Previous studies have demonstrated that reflex
vagal activation after phenylephrine infusion is effective in
suppressing premature ventricular complexes in man; de-
creasing the rate of automatic firing by increased vagal tone
may be the underlying mechanism (12,13). In addition, a
withdrawal of sympathetic tone when carotid sinus nerves
are stimulated after phenylephrine infusion may contribute
to the suppressive effects on frequency of ectopic activity and
bursts of AF; the prolongation of atrial refractory period
caused by sympathetic withdrawal may also play a role in the
lengthening of the coupling intervals of ectopic activity and
bursts of AF (14,15).
On the other hand, phenylephrine infusion had no effect
on suppressing ectopic activity and AF originating in the
SVC in this study. Scherlag et al. (16) have demonstrated
that high-frequency stimulation of cardiac autonomic nerve
in the vicinity of the SVC in dogs induced atrial premature
beats followed by atrial tachycardia and AF; these arrhyth-
mias could be abolished by beta-receptor blockers and
atropine. In the human heart, Gardner et al. (17) showed
that the PVs have a richer supply of cardiac nerves arising
from bilateral vagus nerves and cervical sympathetic ganglia
and trunks compared with the SVC. Thus, the differential
effects of phenylephrine infusion on frequency of ectopic
activity and bursts of AF originating in either the PVs or
SVC may be due to nonuniform vagal innervation in the
human heart. However, the effect of phenylephrine infusion
on focal activity in the SVC was evaluated in only two
patients; therefore, further studies are needed to confirm
these initial results.
Study limitation. A potential limitation of this study was
the use of phenylephrine to induce reflex changes in
autonomic tone. The antiarrhythmic effects might result
from direct alpha receptor stimulation. However, the direct
electrophysiologic effects of phenylephrine are relatively
minor when compared with the indirect reflex changes
(18,19). Furthermore, phenylephrine has no discernible
effect on atrial refractoriness in dogs pretreated with nadolol
and atropine (20). In addition, this study included only
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patients with frequent bursts of paroxysmal AF. Whether
other subgroups of paroxysmal AF are suppressed by phen-
ylephrine infusion or not deserves further investigation.
Conclusions. Frequent bursts of focal AF originating in
the PVs could be initiated by beta-adrenergic stimulation
after isoproterenol infusion and suppressed by change in
autonomic tone after phenylephrine infusion. This finding
implied that autonomic influences may play an important
role in the clinical occurrence of focal AF.
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